The challenges and future of Parkinson’s disease research

Written by Arthur Roach

Neurology Central, speaks to Dr Arthur Roach, Research and Development Director at Parkinson’s UK – the largest charity funder of Parkinson’s disease research in the UK – about recent progress and current challenges involved in Parkinson’s research. In particular, we discuss the status of the anticipated glial cell-derived neurotrophic factor study (GDNF) [1], which investigates whether the growth factor GDNF is capable of restoring dopamine-producing brain cells, and thus slow the course of Parkinson’s. What are your roles and responsibilities as the Research and Development Director at Parkinson’s UK? How do you split your time between your various responsibilities? The Parkinson’s UK...

To view this content, please register now for access

It's completely free